1.1 List of Tables 4
1.2 List of Figures 5

2 Introduction 6
2.1 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Overview 6

3 Products under Development 7
3.1 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development 7
3.2 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Territory 8
3.3 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Regulatory Path 9
3.4 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Estimated Approval Date 10
3.5 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Ongoing Clinical Trials 11

4 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products under Development by Companies 12
4.1 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies - Pipeline Products by Stage of Development 12
4.2 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development 13

5 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies and Product Overview 14
5.1 Boston Scientific Corp Company Overview 14
5.1.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Mayo Clinic Company Overview 17
5.2.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 Medtronic plc Company Overview 19
5.3.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 19
5.4 MicroPort CRM Company Overview 23
5.4.1 MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview 23
5.5 St. Jude Medical LLC Company Overview 28
5.5.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 28
5.6 Teleflex Inc Company Overview 32
5.6.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 32

6 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads- Recent Developments 33
6.1 Nov 19, 2019: Medtronic reports second quarter fincial results for the year 2019 33
6.2 Nov 18, 2019: Integer updates 2019 guidance following customer Chapter 11 filing, no change in prior view of 2020 sales outlook 35
6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 36
6.4 Nov 12, 2019: T2 Biosystems reports third quarter 2019 fincial highlights and provides corporate update 37
6.5 Nov 12, 2019: MRI Interventions reports 62% increase in 2019 third quarter revenue 38

7 Appendix 98
7.1 Methodology 98
7.2 About GlobalData 101
7.3 Contact Us 101
7.4 Disclaimer 101